900000000000526001: REPLACED BY association reference set (foundation metadata concept)

SNOMED CT Concept\SNOMED CT Model Component\Foundation metadata concept (foundation metadata concept)\Reference set\Association type\Historical association reference set (foundation metadata concept)\REPLACED BY association reference set (foundation metadata concept)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module

900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)

900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
REPLACED BY association reference set (foundation metadata concept)	Is a	Historical association reference set (foundation metadata concept)	true	Inferred relationship	Some

Members	targetComponentId
Depo-provera injection given	Injection of medroxyprogesterone acetate (procedure)
Depot contraceptive given	Administration of depot contraceptive (procedure)
Depression NOS	Depressive disorder
Depression NOS	Depressive disorder
Depressor anguli oris flap	Depressor anguli oris myocutaneous flap
Depth of cells in anterior chamber	Depth of anterior chamber
Derangement of meniscus, NEC	Derangement of meniscus
Dermatitis atrophicans	Acrodermatitis atrophicans chronica
Dermatitis caused by drug AND/OR medicine taken internally	Dermatitis caused by substance taken via oral route (disorder)
Dermatitis caused by substance taken internally	Dermatitis caused by substance taken via oral route (disorder)
Dermatitis due to other specified substance taken internally	Dermatitis caused by substance taken via oral route (disorder)
Dermatofibroma, no International Classification of Diseases for Oncology subtype	Dermatofibroma (morphologic abnormality)
Dermatoses NOS	Disorder of skin (disorder)
Dermatoses NOS	Disorder of skin (disorder)
Dermatosis attributable to coumarin anticoagulant	Dermatosis caused by coumarin (disorder)
Dermatosis of suspected viral etiology	Suspected viral infection of skin (situation)
Dermatosis resulting from immunosuppressive therapy	Dermatosis caused by immunosuppressant
Dermographism	Dermatographic urticaria
Deroofing of cyst of organ NOC	Surgical procedure (procedure)
Desflurane 99% liquid	Product containing precisely desflurane 990 milligram/1 milliliter conventional release solution for inhalation (clinical drug)
Desloratadine 0.5mg/mL syrup	Product containing precisely desloratadine 500 microgram/1 milliliter conventional release oral solution (clinical drug)
Desloratadine 2.5mg/pseudoephedrine 120mg m/r tablet	Product containing only desloratadine and pseudoephedrine in oral dose form (medicinal product form)
Desloratadine 2.5mg/pseudoephedrine 120mg prolonged-release oral tablet	Product containing only desloratadine and pseudoephedrine in oral dose form (medicinal product form)
Desloratadine 5mg/pseudoephedrine 240mg m/r tablet	Product containing only desloratadine and pseudoephedrine in oral dose form (medicinal product form)
Desloratadine 5mg/pseudoephedrine 240mg prolonged-release oral tablet	Product containing only desloratadine and pseudoephedrine in oral dose form (medicinal product form)
Desmoplastic fibroma	Desmoplastic fibroma
Desmoplastic juvenile ganglioglioma	Desmoplastic infantile astrocytoma
Desmopressin acetate 0.01% solution	Product containing only desmopressin (medicinal product)
Desoximetasone 0.5% gel	Product containing only desoximetasone (medicinal product)
Destruction of intervertebral disc by other specified method	Vertebral column destructive procedure
Destruction of lesion of female perineum	Destruction of lesion of perineum
Destruction of lesion of female perineum NEC	Destruction of lesion of perineum
Destruction of lesion of organ NOC NOS	Destruction of lesion
Destruction of lesion of organ NOC OS	Destruction of lesion
Destruction of tissue of heart	Catheter ablation of tissue of heart
Destruction of tissue of pharynx	Pharynx destructive procedure
Destructive procedure of facial bone	Facial bone destructive procedure
Destructive procedure on fetus to facilitate delivery	Destruction of fetus
Desulfotomaculum orientis	Desulfosporosinus orientis
Detachment of left retina co-occurrent with retinal defect	Detachment of left retina with retinal break
Detachment of right retina co-occurrent with retinal defect	Detachment of right retina with retinal break
Detection of poison	Measurement of substance (procedure)
Detrusor hyperreflexia of bladder	Neurogenic detrusor overactivity
Detrusor instability	Idiopathic detrusor overactivity (disorder)
Detrusor instability	Idiopathic detrusor overactivity (disorder)
Detrusor instability	Idiopathic detrusor overactivity (disorder)
Detrusor instability of bladder	Idiopathic detrusor overactivity (disorder)
Developmental handicap screening	Screening for developmental disorder (procedure)
Dexamethasone 0.5mg/5mL elixir	Dexamethasone 100 microgram/mL oral solution
Dexamethasone sodium phospha 0.05%	Dexamethasone only product in ocular dose form
Dexamethasone sodium phosphate 0.05% conventional release eye drops	Dexamethasone only product in ocular dose form
Dexamethasone sodium phosphate 0.05% single-use eye drops	Dexamethasone only product in ocular dose form
Dexamethasone+hypromellose 0.1%/0.5% eye drops	Dexamethasone 1 mg/mL and hypromellose 5 mg/mL eye solution
Dexamfetamine - non-pharmaceutical	Dexamfetamine
Dexlansoprazole 30mg dual delayed-release oral capsule	Dexlansoprazole 30 mg gastro-resistant oral capsule
Dexlansoprazole 30mg m/r capsule	Dexlansoprazole 30 mg gastro-resistant oral capsule
Dexlansoprazole 60mg dual delayed-release oral capsule	Product containing precisely dexlansoprazole 60 milligram/1 each gastro-resistant oral capsule (clinical drug)
Dexlansoprazole 60mg m/r capsule	Product containing precisely dexlansoprazole 60 milligram/1 each gastro-resistant oral capsule (clinical drug)
Dexmethylphenidate 20mg m/r capsule	Product containing precisely dexmethylphenidate hydrochloride 20 milligram/1 each prolonged-release oral capsule (clinical drug)
Dexmethylphenidate 20mg prolonged-release oral capsule	Product containing precisely dexmethylphenidate hydrochloride 20 milligram/1 each prolonged-release oral capsule (clinical drug)
Dexmethylphenidate 5mg m/r capsule	Dexmethylphenidate hydrochloride 5 mg prolonged-release oral capsule
Dexmethylphenidate 5mg prolonged-release oral capsule	Dexmethylphenidate hydrochloride 5 mg prolonged-release oral capsule
Dexon patch	Prosthetic patch
Dexon suture	Polyglycolic acid suture
Dexrazoxane hydrochloride	Product containing dexrazoxane (medicinal product)
Dextran 40 (10%) injection solution 500mL bottle	Dextran 40 100 mg/mL solution for injection
Dextran 40 10% injection	Dextran 40 100 mg/mL solution for injection
Dextran 40/dextrose 5% infusion solution bag	Dextran 40 100 mg/mL solution for injection
Dextran 40/sodium chloride 0.9% infusion solution bag	Dextran 40 100 mg/mL solution for injection
Dextran 70 in sodium chloride 7.5% infusion	Dextran 70 only product in parenteral dose form
Dextran 70 in sodium chloride 7.5% infusion solution	Dextran 70 only product in parenteral dose form
Dextran 70/dextrose 5% infusion solution bag	Dextran 70 only product in parenteral dose form
Dextran 70/sodium chloride 0.9% infusion solution bag	Dextran 70 only product in parenteral dose form
Dextran allergy	Non-allergic hypersensitivity to dextran (finding)
Dextroamphetamine sulfate 10mg m/r capsule	Dexamfetamine only product in oral dose form
Dextroamphetamine sulfate 10mg prolonged-release oral capsule	Dexamfetamine only product in oral dose form
Dextroamphetamine sulfate 15mg m/r capsule	Dexamfetamine only product in oral dose form
Dextroamphetamine sulfate 15mg prolonged-release oral capsule	Dexamfetamine only product in oral dose form
Dextroamphetamine sulfate 5mg m/r capsule	Dexamfetamine only product in oral dose form
Dextroamphetamine sulfate 5mg prolonged-release oral capsule	Dexamfetamine only product in oral dose form
Dextromethorphan 7.5mg pastille	Dextromethorphan 7.5 mg oromucosal lozenge
Dextromethorphan hydrobromide + promethazine hydrochloride 15mg/6.25mg liquid	Dextromethorphan hydrobromide 3 mg/mL and promethazine hydrochloride 1.25 mg/mL oral solution
Dextromethorphan hydrobromide 6.67mg/5mL syrup	Dextromethorphan hydrobromide 1.33 mg/mL oral solution
Dextromethorphan hydrobromide 7.5mg/5mL oral elixir	Product containing precisely dextromethorphan hydrobromide 1.5 milligram/1 milliliter conventional release oral solution (clinical drug)
Dextromethorphan hydrobromide 7.5mg/5mL syrup	Product containing precisely dextromethorphan hydrobromide 1.5 milligram/1 milliliter conventional release oral solution (clinical drug)
Dextromethorphan hydrobromide allergy	Allergy to dextromethorphan
Dextrose + lidocaine hydrochloride 7.5%ww/1.5%ww injection	Lidocaine only product in parenteral dose form
Dextrose 10% solution	Product containing only glucose (medicinal product)
Dextrose 20% solution	Product containing only glucose (medicinal product)
Dextrose 25% solution	Product containing only glucose (medicinal product)
Dextrose 30% solution	Product containing only glucose (medicinal product)
Dextrose 40% solution	Product containing only glucose (medicinal product)
Dextrose 60% in water conventional release solution for infusion 1000mL bag	Product containing precisely glucose 200 milligram/1 milliliter conventional release solution for injection (clinical drug)
Dextrose 60% in water conventional release solution for infusion 500mL bag	Product containing precisely glucose 600 milligram/1 milliliter conventional release solution for injection (clinical drug)
Dextrose 60% in water intravenous solution 1000mL bag	Product containing precisely glucose 200 milligram/1 milliliter conventional release solution for injection (clinical drug)
Dextrose 60% in water intravenous solution 500mL bag	Product containing precisely glucose 600 milligram/1 milliliter conventional release solution for injection (clinical drug)
Dextrose 60% solution	Product containing precisely glucose 200 milligram/1 milliliter conventional release solution for injection (clinical drug)
Dextrose 60g injection	Product containing precisely glucose 600 milligram/1 milliliter conventional release solution for injection (clinical drug)
Dextrose 7.5%ww/lidocaine hydrochloride 1.5%ww injection solution vial	Lidocaine only product in parenteral dose form
Dextrose 70% solution	Product containing precisely glucose 200 milligram/1 milliliter conventional release solution for injection (clinical drug)
Dextrothyroxine sodium allergy	Allergy to dextrothyroxine (finding)

Start Previous Page 43 of 195 Next End

Reference Sets

Reference set descriptor

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
900000000001156010	REPLACED BY association reference set (foundation metadata concept)	en	Fully specified name	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
900000000001157018	REPLACED BY association reference set	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)